Endocrine, Metabolic & Immune Disorders - Drug Targets
Title:Editorial (Thematic Issue: Cow’s Milk Allergy: Where do we Stand?)
Volume: 14 Issue: 1
Author(s): Kostas N. Priftis
Affiliation:
Export Options
About this article
Cite this article as:
Priftis N. Kostas, Editorial (Thematic Issue: Cow’s Milk Allergy: Where do we Stand?), Endocrine, Metabolic & Immune Disorders - Drug Targets 2014; 14 (1) . https://dx.doi.org/10.2174/1871530314666140121142447
DOI https://dx.doi.org/10.2174/1871530314666140121142447 |
Print ISSN 1871-5303 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3873 |
Article Metrics

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Imaging in Diabetic Retinopathy: A Review of Current and Future Techniques
Current Diabetes Reviews The Pharmacological Treatment of Cachexia
Current Drug Targets Pharmacogenomics in Drug Induced Liver Injury
Current Drug Metabolism Early Development of Therapeutic Biologics - Pharmacokinetics
Current Drug Metabolism Metabolic Stress and Inflammation: Implication in Treatment for Neurological Disorders
CNS & Neurological Disorders - Drug Targets Clopidogrel in Secondary Ischemic Stroke Prevention
Recent Patents on Cardiovascular Drug Discovery Life or Death? A Physiogenomic Approach to Understand Individual Variation in Responses to Hemorrhagic Shock
Current Genomics Hypothalamic Leptin and Ghrelin Signaling as Targets for Improvement in Metabolic Control
Current Pharmaceutical Design Antihypertensive Efficacy and Tolerability of Aliskiren/Amlodipine Single- Pill Combinations in Patients with an Inadequate Response to Aliskiren Monotherapy¥
Current Vascular Pharmacology Presystemic Metabolism of Orally Administered Peptide Drugs and Strategies to Overcome It
Current Drug Metabolism Cancer Cachexia: Molecular Targets and Pathways for Diagnosis and Drug Intervention
Endocrine, Metabolic & Immune Disorders - Drug Targets Dyslipidemia Treatment and Cardiovascular Disease in the Renal Patient
Current Pharmaceutical Design Editorial (Thematic Issue: Novel Data on the Pathogenesis of Atherosclerosis, Treatment Targets, and New Therapeutic Interventions in Lipid-Related Cardiovascular Risk Factors)
Current Pharmaceutical Design Urinary Exosomal Lipidomics Reveals Markers for Diabetic Nephropathy
Current Metabolomics The Interaction between KCNJ11 Gene Polymorphism and Refined Carbohydrates Intake on Obesity in Indonesian Adolescents
Current Nutrition & Food Science The Role of Intravenous Dihydropyridine Calcium Channel Blockers in the Perioperative Management of Patients Undergoing Coronary Artery Bypass Surgery
Current Vascular Pharmacology Meet Our Co-Editor Prof. Dr. Xiaofeng Charles Zhou
MicroRNA Hyperandrogenism, Insulin Resistance and Hyperinsulinemia as Cardiovascular Risk Factors in Diabetes Mellitus
Current Diabetes Reviews p38 MAP Kinase Mediated Proteoglycan Synthesis as a Target for the Prevention of Atherosclerosis
Cardiovascular & Hematological Disorders-Drug Targets Epidemiology of Gout: Perspectives from the Past
Current Rheumatology Reviews